Pfizer Fights Chinese Drugmaker Over Chantix Generic
Pharmaceutical giant Pfizer and company subsidiaries have accused China-based competitor Viwit Pharmaceuticals of violating patents for anti-smoking drug Chantix in the pursuit of selling a generic, according to a complaint filed...To view the full article, register now.
Already a subscriber? Click here to view full article